Skip to main content
Log in

Effects of cefotaxime, clindamycin, mezlocillin, and piperacillin on mouse sarcoma L-1 tumor

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

For the study described in the paper, the effects of 10 days' chemotherapy with cefotaxime, clindamycin, mezlocillin, and piperacillin on local tumor growth and on spontaneous or artificial metastatic spread into the lungs were studied. For the animal tumor model Balb/c mice and the mouse sarcoma L-1 tumor were used. Chemotherapy was administered before, immediately after, or some time after the injection of tumor cells. The antibiotic dosage given to mice was calculated on a body weight basis from the doses recommended for humans. Cefotaxime and clindamycin did not influence the animal tumor model, whereas mezlocillin and piperacillin showed positive or negative effects depending on the chemotherapy schedule. In vitro none of the four antibiotics caused cytotoxic activity in cell cultures of mouse sarcoma L-1, human lung cancer E-14, or human malignant melanoma MEW.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Becker S, Kiessling R, Lee N, Klein G (1978) Modulation of sensitivity of natural killer cell lysis after in vitro explantation of mouse lymphoma. J Natl Cancer Inst 61:1495–1498

    Google Scholar 

  2. Bodey GP, Bockley M, Sathe YS, Freireich EJ (1966) Quantitative relationship between circulating leukocytes and infection in patients with acute leukaemia. Ann Intern Med 64:328–340

    CAS  PubMed  Google Scholar 

  3. Bodey GP, Hersh EM, Validiviese M (1975) Effects of cytotoxic drugs and immunosuppressive agents on the immune system. Postgrad Med J 58:67–74

    Google Scholar 

  4. Fainstein V, Bodey GP (1982) Bacterial infections in cancer patients. An overview. In: Jeljaszewicz J, Pulverer G, Roszkowski W (eds) Bacteria and cancer. Academic Press, London New York, 1983, pp 435–451

    Google Scholar 

  5. Finch R (1980) Immunomodulating effects of antimicrobial agents. J Antimicrob Chemother 6:691–693

    Google Scholar 

  6. Hanna N, Burton RC (1981) Definite evidence that natural killer cells inhibit experimental tumor metastasis in vivo. J Immunol 127:1754–1758

    Google Scholar 

  7. Hill RP, Bush RS (1969) A lung colony assay to determine radiosensitivity of the cells of a solid tumor. Int J Radiat Biol 15:435–444

    Google Scholar 

  8. Roszkowski W, Lipinska R, Roszkowski K, Jeljaszewicz J, Pulverer G (1984) Rifampicin-induced suppression of antitumor immunity. Med Microbiol Immunol 172:197–205

    Google Scholar 

  9. Roszkowski W, Ko HL, Jeljaszewicz J, Pulverer G (1984) Antibiotics and host immunity: Effects of cefotaxime, amikacin and mezlocillin. Zentralbl Bakteriol [Orig A] Suppl. 13 (in press)

  10. Ruben FL, Winkelstein A, Fotadis IG, Dessauer P (1973) Rifampicin and immunosuppression. Lancet 2:978

    Google Scholar 

  11. Weissman IL (1980) Tumor immunology, T cell maturation and T cell neoplasia. Prog Exp Tumor Res 25:193–218

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Fellows of the Alexander von Humboldt Foundation

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roszkowski, K., Ko, H.L., Roszkowski, W. et al. Effects of cefotaxime, clindamycin, mezlocillin, and piperacillin on mouse sarcoma L-1 tumor. Cancer Immunol Immunother 18, 164–168 (1984). https://doi.org/10.1007/BF00205506

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00205506

Keywords

Navigation